ReviewDrug design, development and therapy2017

Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy.

David Buchbinder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.